Optimisation of intramuscular dosage of dexmedetomidine for hypotensive anesthesia in functional endoscopic sinus surgery- a prospective randomized double blind study
Abstract
Background of the study: Dexmedetomidine, a selective alpha-2 agonist which is being used widely in anesthesia and critical care practice. It has both sedative and analgesic property. The studies on intravenous usage of dexmedetomidine are numerous but not with intramuscular route. With this background we conducted a study on optimisation of intramuscular dosage of dexmedetomidine in patients undergoing functional endoscopic sinus surgery.
Aim and objectives:To optimize the dosage of intramuscular dexmedetomidine in patients undergoing functional endoscopic sinus surgery for providing bloodless field for the surgeon.
Materials and methods: We enrolled a total of 50 patients who have planned to undergo functional endoscopic sinus surgery under general anesthesia. After randomization, group D1 patients received intramuscular dexmedetomidine at the dosage of 0.5mcg/kg and group D2 1mcg/kg respectively. Hemodynamic parameters like blood pressure (MAP) and heart rate were recorded at regular intervals. The surgical field score was done by the operating ENT surgeon using Boerzaart scale. The targeted mean arterial blood pressure was kept between 55-65mmHg. The other parameters like additional requirement of opioid, usage of other vasodilators, time to emergence along with other side effects were noted peri-operatively.
Results:After statistical analysis, the mean duration of surgery in both groups were 92±21.8 and 85±22.15 minutes respectively. The targeted mean arterial blood pressure was achieved in the patients who have received 1mcg/kg of dexmedetomidine (Group D2) intramuscularly. The surgeon felt satisfied with bloodless operating field in the patients who received 1mcg/kg of dexmedetomidine.
Conclusion:From our study we concluded that 1mcg/kg of dexmedetomidine will be the adequate intramuscular dose for both premedication and hypotensive agent in functional endoscopic sinus surgery.
Downloads
References
2. Shams T, El Bahnasawe NS, Abu-Samra M, El-Masry R. Induced hypotension for functional endoscopic sinus surgery. A comparative study of dexmedetomidine versus esmolol. Saudi J Anaesth. 2013 Apr;7(2):175-80. doi: 10.4103/1658-354X.114073.
3. Kamibayashi T, Maze M. Clinical uses of alpha 2-adrenergic agonists. Anesthesiology. 2000 Nov;93(5):1345-9.
4. Gertler R, Brown HC, Mitchell DH, Silvius EN. Dexmedetomidine: a novel sedative –analgesic agent. Proc (Bayl Univ Med Cent). 2001 Jan;14(1):13-21.
5. Aantaa R, Kanto J, Scheinin M, Kallio A, Scheinin H. Dexmedetomidine, an alpha 2-adrenoceptor agonist, reduces anesthetic requirements for patients undergoing minor gynecologic surgery. Anesthesiology. 1990 Aug;73(2):230-5.
6. Virkkilä M1, Ali-Melkkilä T, Kanto J, Turunen J, Scheinin H. Dexmedetomidine as intramuscular premedication in outpatient cataract surgery. A placebo-controlled dose-ranging study. Anaesthesia. 1993 Jun;48(6):482-7.
7. Scheinin H, Karhuvaara S, Olkkola KT, et.al. Pharmacodynamics and pharmacokinetics of intramuscular dexmedetomidine. ClinPharmacolTher 1992;52(5):537-46
8. Eberhart LH, Folz BJ, Wulf H, Geldner G. Intravenous anesthesia provides optimal surgical conditions during microscopic and endoscopic sinus surgery. Laryngoscope. 2003 Aug;113(8):1369-73.
9. Clincikas D, Ivaskevicius S. Application of controlled artrial hypotension in endoscopic rhino-surgery. Medicina (Kaunas). 2003;39(9):852-9.
10. Boezaart AP, van der Merwe J, Coetzee A. Comparison of sodium nitroprusside –and esmolol-induced controlled hypotension for functional endoscopic sinus surgery. Can J Anaesth. 1995 May;42(5 Pt 1):373-6.
11. Alimian M, Mohseni M. The effect of intravenous tranexamic acid on blood loss and surgical field quality during endoscopic sinus surgery: a placebo –controlled clinical trial.J Clin Anesth. 2011 Dec;23(8):611-5. doi: 10.1016/j.jclinane.2011.03.004.
12. Wormald PJ, Van Renen G, Perks J, Jones JA, Langton-Hewer CD. The effect of the total intravenous anaesthesia compared with inhalational anesthesia on the surgical field during endoscopic sinus surgery. Am J Rhinol. 2005 Sep-Oct;19(5):514-20.
13. Scheinin H, Jaakola ML, Sjovall S, Ali-Melkkila T, KaukinenS, Turunen J. Intramusculardexmedetomidine as premedication for general anaesthesia. A comparative multicenter study. Anesthesiology. 1993 Jun;78(6):1065-75.
14. NaglaAbdalla, Amera H. Soliman. The effects of dexmedetomidine premedication on cortisol and interleukin-6 in patients undergoing major abdominal surgery. EG.J.Anaesth 2003;19:283-290
15. Durmus M, But AK, Dogan Z, Yucel A, Miman MC, Ersey Mo. Effecct of dexmedetomidine on bleeding during tympanoplasty or septoplasty. Eur J Anaesthesiol. 2007 May;24(5):447-53. Epub 2007 Jan 23.
16. Ayoglu H, Yapakai O, Ugur MB, Uzun L, Altunkaya H, Ozer Y. Effectiveness of dexmedetomidine in reducing bleeding during septoplasty and tympanoplastyopertaions. J Clin Anesth. 2008 Sep;20(6):437-41. doi: 10.1016/j.jclinane.2008.04.008.
17. Guven DG, Demiraran Y, Sezen G, Kepek O, Iskender A. Evaluation of outcomes in patients given dexmedetomidine in functional endoscopic sinus surgery. Ann Otol Rhinol Laryngol. 2011 Sep;120(9):586-92.
OAI - Open Archives Initiative
